Progyny, a New York-based digital health care company specialising in fertility and in-vitro fertilisation has closed its Series B fundraising round having raised close to $15m. This comes at the same time as the company launched its mobile app which offers a comprehensive and personal experience for consumers seeking fertilisation services. The firm is now looking forward to expanding into new markets including China, where it will be launching an online platform that allows users to find out about their options before they even go through with it.
Progyny, a New York-based digital health care company specialising in fertility and in-vitro fertilisation has closed its Series B fundraising round having raised close to $15m. This comes at the same time as the company launched its mobile app which offers a comprehensive and personal experience for consumers seeking fertilisation services. The app will help connect consumers with fertilisation services in the local area based on their needs, showing the potential options and their prices.